Lecture 2 Flashcards

1
Q

What is drug discovery?

A

a process during which a synthetic or naturally-occurring chemical (drug lead) is found to have a profile of biological activities that can be applied for disease treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name some environmental influences that lead to diseases.

A
  1. long-term phenotype changes sucg as weight gain, muscle weakness or depression
  2. stressful environment
  3. smoking (initiated as a result of social factors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does exposure to stressful environment lead to?

A

activate hypothalamopituitary system and therby increase adrenal steroid secretion, which affects:

  1. gene transcription in cells and tissues
  2. salt metabolism
  3. immune responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The increase in adrenal steroid secretion affects:

A
  1. gene transcription in cells and tissues
  2. salt metabolism
  3. immune responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the issues with current drug discovery process?

A
  1. long time between initial conception and final marketing
  2. high attrition rate: 1 out of 5000 compound
  3. costly process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some potential ways to improve drug discovery process?

A
  1. identify and validate more targets in a faster pace
  2. eliminate problematic candidates earlier to reduce costs
  3. enable targeted therapeutics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the choice of therapeutic area often based on?

A
  1. Available expertise and technology
  2. Patent positions
  3. Pharmaeconomics
  4. Unmet medical need
  5. Potential market size and patient population
  6. Existing competition and market dominance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define orphan drug

A

a pharmaceutical agent that has been developed specifically to treat a rare medical condition (an orphan disease) that inflicts less than 200,000.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The assignment of orphan status has resulted in medical breakthroughs that
would not have otherwise been achieved due to the economics of drug
research and development.

True or false

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do orphan drug regulations assist in the development of orphan drugs as it may have poor pharmaeconomics?

A
  • fewer patients can be tested for phase III clinical trials as it is an orphan disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What interventions are provided by the gpvernment on behalf of orphan drug development?

A
  1. tax inxentives
  2. enhanced patent protection and marketing rights
  3. clinical research financial subsidization
  4. creating gov’t run enterprise to engage in research and development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name an orphan disease

A

Blepharospams

-Overactive blinking, eventually leading to the inability to open the eye lids and thus
blindness
-treated with Botox (botulinium toxin type A)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List some age-related diseases

A

Alzheimer’s disease
Cancer
Chronic renal failure
coronary heart disease
diabetes
osteoporosis
parkinson’s disease
stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the different approaches to CNS drug discovery?

A
  1. pathology to drug
  2. Reverse translation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe ‘pathology to drug’ approach in CNS drug discovery.

A

Analysis of disease pathiophysiology results in identification of novel disease pathways

  1. selection of novel drug targets and parellel development of disease relevant models for screening
  2. select drug candidates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What factors/properties of a cell leads to disease?

A

growth
shape
differentiation
movement
division
apoptosis
metabolism
scretion
excitability

17
Q

What factors/properties of tissue leads to disease?

A

growth
atrophy
repair
inflammation
infection
ischaemia
necrosis

18
Q

List some ‘malfunctions’ of physiological systems

A

Hypoxia
hyperglycaemia
hypertension
heart failure
renal failure
epilepsy
hemiplegia
obesity

19
Q

Describe the ‘pathology to drug’ approach in CNS drug discovery.

A

Analysis of disease pathophysiology results in the identification of novel disease pathways.

–> select over drug targets and develop disease models

20
Q

Describe the ‘reverse translation’ approach in CNS drug discovery.

A

understanding current pharmacotherapy to
identify the mechanism of action and
develop animal models to screen for compounds

–> drug candidates similar properties as existing drugs

21
Q

Prozac is an antidepressant of which class?

A

selective serotonin reuptake inhibitor (SSRI) class

22
Q

What is 5-HT?

23
Q

What are the 2 paradigms in target discovery?

A
  1. physiology-based approach
  2. target-based approach
24
Q

Briefly explain the physiological approach in drug discovery

A
  • Follows physiological readouts
  • Drug targets and the mechanism of action would be deduced later based on specific pharmacological properties.
25
Q

Briefly explain the ‘target-based approach’ in drug discovery

A
  1. identify possible therapeutic target and its role in disease
26
Q

What has been the main driver of ‘target-based approach’?

A

genomics revolution

27
Q

What are the main families of proteins known to be likely drug targets?

A

G protein-coupled receptors (GPCRs)
kinases
proteases

–> acheiving selectivity for just one member of such a family can be challenging

28
Q

Give some examples of drug targets

A
  1. ion channels
  2. enzyme inhibitor
  3. GPCR
  4. transmembrane agonist
29
Q

What is a transmembrane agonist?

A

a type of ligand or molecule that binds to a receptor located on the cell membrane and triggers a cellular response or activation.

30
Q

How are novel endogenous ligands for orphan receptors (such as GPCRs) discovered?

A
  1. transfection
    –> expression of receptor in heterologous cells
  2. second messenger
    –> observe changes in second messenger levels
  3. tissue extraction (expected to contain the transmitter)
    –> tested for their ability to activate orphan receptor
  4. fractionation
    –> activitites of fractions monitored
  5. isolations and structure determination
31
Q

What is a druggable target?

A

Generally, a druggable target is a protein or other functional biomacromolecule whose activity can be modulated by ligands with drug-like properties.

32
Q

What is the role of biologists in drug discovery process?

A

discover gene products whose activity can be modulated by high-affinity ligands

33
Q

What is the role of medicinal chemists in drug discovery process?

A

responsible for dispensing drug-like structural and physicochemical properties to ‘hits’ and ‘leads’

34
Q

What is the role of pharmacologists in drug discovery process?

A

ensure clinical candidates are active and safe

35
Q

What is the role of clinicians in drug discovery process?

A

ensure drug candidates are efficaceous, useful and safe

36
Q

What are some factors that may affect the druggability of a target?

A
  1. Cellular location
    –> central vs perpheral; cell surface vs intracellular
  2. Development of resistance and tolerance
    –> analgesics: drug addiction
  3. transport mechanisms
    –> penetration through blood brain barrier
  4. side effects
    –> affect productivity
  5. toxicity
    –> not a major concern in life-threating conditions
37
Q

The disparity between the number of transmitters to be matched and the much larger number of orphan GPCRs led to the hypothesis that many transmitters remain to be discovered.

True or False.